Citation Impact
Citing Papers
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research
2015
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2008
Clinician’s Guide to Prevention and Treatment of Osteoporosis
2014 Standout
American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis — 2016--Executive Summary
2016
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
2001 Standout
Child abuse: Adolescent records vs. adult recall
1990 Standout
Health benefits of physical activity: the evidence
2006 Standout
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
2010
Osteoporosis
2019 Standout
Vitamin D insufficiency increases bone turnover markers and enhances bone loss at the hip in patients with established vertebral osteoporosis
1999
Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate
2004
Exogenous Testosterone or Testosterone with Finasteride Increases Bone Mineral Density in Older Men with Low Serum Testosterone
2004
Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
2010 Standout
Clinical utility of denosumab for treatment of bone loss in men and women
2011
The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
1995 Standout
Prevalence of Severe Hypovitaminosis D in Patients With Persistent, Nonspecific Musculoskeletal Pain
2003
Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management
1990
Prevention of Corticosteroid Osteoporosis -- A Comparison of Calcium, Calcitriol, and Calcitonin
1993
In elderly men and women treated for osteoporosis a low creatinine clearance of <65 ml/min is a risk factor for falls and fractures
2005
The β-Thalassemias
1999 Standout
Recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis
1996
Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis
2007
Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society
2007 Standout
Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline
2011 Standout
The role of vitamin D in corticosteroid-induced osteoporosis: A meta-analytic approach
1999
OPG, RANK-L, bone metabolism, and BMD in patients on peritoneal dialysis and hemodialysis
2006
Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis
2010 Standout
Magnesium deficiency: Possible role in osteoporosis associated with gluten-sensitive enteropathy
1996
Fracture rate associated with quality metric-based anti-osteoporosis treatment in glucocorticoid-induced osteoporosis
2015
Vitamin D Deficiency
2007 Standout
Osteoporosis in men with prostate carcinoma receiving androgen‐deprivation therapy
2004
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Pharmacology of bisphosphonates
2011
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
2006 Standout
Bone density, mineral content, and cortical index in patients with thalassemia major and the correlation to their bone fractures, blood transfusions, and treatment with desferrioxamine
1992
Osteoporosis: now and the future
2011 Standout
Bone Mineral Density Thresholds for Pharmacological Intervention to Prevent Fractures
2004
Glucocorticoid-induced Osteoporosis
2000
Pharmacologic management of neuropathic pain: Evidence-based recommendations
2007 Standout
Osteoporosis in men: Epidemiology, diagnosis, prevention, and treatment
2004
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards
2010
Risedronate, an effective treatment for glucocorticoid-induced bone loss in CKD patients with or without concomitant active vitamin D (PRIUS-CKD)
2006
Current options for the management of postmenopausal osteoporosis
2011
Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement
2003 Standout
Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease
2004 Standout
The Effects of Parathyroid Hormone, Alendronate, or Both in Men with Osteoporosis
2003
Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression
1996 StandoutNobel
The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation
2006
Cancer treatment and survivorship statistics, 2012
2012 Standout
Identification and Assessment of Adherence-Enhancing Interventions in Studies Assessing Medication Adherence Through Electronically Compiled Drug Dosing Histories: A Systematic Literature Review and Meta-Analysis
2013
Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
2006 Standout
Partial adherence: a new perspective on health economic assessment in osteoporosis
2011
Teriparatide or Alendronate in Glucocorticoid-Induced Osteoporosis
2007
Effects of pharmaceutical care on adherence and persistence to bisphosphonates in postmenopausal osteoporotic women
2010
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Intravenous ibandronate injections in postmenopausal women with osteoporosis: One‐year results from the dosing intravenous administration study
2006
American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis
2010
Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
2009
A blinded randomized controlled trial of motivational interviewing to improve adherence with osteoporosis medications: design of the OPTIMA trial
2009
Glucocorticoid-induced osteoporosis
2000
A Prospective Randomized Study for the Treatment of Bone Loss with Vitamin D During Kidney Transplantion in Children and Adolescents
2004
Towards a diagnostic and therapeutic consensus in male osteoporosis
2011
Osteoporosis: burden, health care provision and opportunities in the EU
2011
The structural basis of bone fragility in men
1999
Effects of teriparatide versus alendronate for treating glucocorticoid‐induced osteoporosis: Thirty‐six–month results of a randomized, double‐blind, controlled trial
2009
Frailty in elderly people
2013 Standout
Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3 analogues: a review with meta-analysis of randomized controlled trials including organ transplantation studies
2004
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Osteoporosis in Men
2008
Vitamin D deficiency: a worldwide problem with health consequences
2008 Standout
Relative in Vitro Efficacy of the Phosphate Binders Lanthanum Carbonate and Sevelamer Hydrochloride
2007 StandoutNobel
Riding the Crest of the Teachable Moment: Promoting Long-Term Health After the Diagnosis of Cancer
2005 Standout
American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis — 2016
2016
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Magnesium in Man: Implications for Health and Disease
2014 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Primary Biliary Cirrhosis
1987 Standout
Fracture Prediction After Discontinuation of 4 to 5 Years of Alendronate Therapy
2014
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications
2001 Standout
Systematic Review: Opioid Treatment for Chronic Back Pain: Prevalence, Efficacy, and Association with Addiction
2007
Interventions for enhancing medication adherence
2008 Standout
Prevention and Treatment of Glucocorticoid-Induced Osteoporosis: A Comparison of Calcitriol, Vitamin D Plus Calcium, and Alendronate Plus Calcium
2003
Sexual Dimorphism in Vertebral Fragility Is More the Result of Gender Differences in Age-Related Bone Gain Than Bone Loss
2001
Glucocorticoid Therapy for Immune-Mediated Diseases: Basic and Clinical Correlates
1993
Reversibility of Calcitriol-Induced Medial Artery Calcification in Rats With Intact Renal Function
2006
Incidence and Economic Burden of Osteoporosis-Related Fractures in the United States, 2005–2025
2006 Standout
Osteoporosis Due to Cancer Treatment: Pathogenesis and Management
2000
Osteoporosis in Men
2008
Parathyroid Hormone and Teriparatide for the Treatment of Osteoporosis: A Review of the Evidence and Suggested Guidelines for Its Use
2005
Osteoporosis Treatment Efficacy for Men: A Systematic Review and Meta‐Analysis
2016
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
2000 Standout
Interventions for enhancing medication adherence
2014 Standout
Rapid Evolution of RNA Genomes
1982 StandoutScience
Guidelines for Adult Stroke Rehabilitation and Recovery
2016 Standout
Opioid Prescriptions for Chronic Pain and Overdose
2010 Standout
Impact of bone marker feedback on adherence to once monthly ibandronate for osteoporosis among Asian postmenopausal women
2009
Estrogen-induced osteogenesis in intact female mice lacking ERβ
2002 StandoutNobel
Effects of combined alendronate and alfacalcidol on prevention of fractures in osteoporosis patients: a network meta-analysis.
2015
Osteoporosis in Men: An Endocrine Society Clinical Practice Guideline
2012
Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association
2016 Standout
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study.
2008
Immunohistological demonstration of respiratory syncytial virus antigens in Paget disease of bone.
1981
Bone metabolism and disease in chronic kidney disease
2003
Prevention of early postmenopausal bone loss: controlled 2‐year study in 315 normal females
1980
Vascular Calcification
2008 Standout
Interventions for preventing falls in older people living in the community
2012 Standout
Bone disease in primary biliary cirrhosis: Reversal of osteomalacia with oral 25-hydroxyvitamin D
1980
Works of J. D. Ringe being referenced
A reappraisal of generic bisphosphonates in osteoporosis
2011
Risedronate dosing before breakfast compared with dosing later in the day in women with postmenopausal osteoporosis
2009
Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study
2005
Three-monthly ibandronate bolus injection offers favourable tolerability and sustained efficacy advantage over two years in established corticosteroid-induced osteoporosis
2003
Intermittent intravenous ibandronate injections reduce vertebral fracture risk in corticosteroid-induced osteoporosis: results from a long-term comparative study
2003
Alendronate treatment of established primary osteoporosis in men: 3-year results of a prospective, comparative, two-arm study
2004
Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis
2004
Avoidance of Vertebral Fractures in Men with Idiopathic Osteoporosis by a Three Year Therapy with Calcium and Low-Dose Intermittent Monofluorophosphate
1998
Prevention and therapy of osteoporosis: the roles of plain vitamin D and alfacalcidol
2004
Active vitamin D metabolites in glucocorticoid-induced osteoporosis
1997
Salmon calcitonin in the therapy of corticoid-induced osteoporosis
1987
Potential of alfacalcidol for reducing increased risk of falls and fractures
2009
Treatment of Male Osteoporosis: Recent Advances with Alendronate
2002
Therapie der Glucocorticoid-induzierten Osteoporose mit Alfacalcidol/Kalzium und Vitamin D/Kalzium
2000
Treatment of Glucocorticoid-Induced Osteoporosis with Alfacalcidol/Calcium Versus Vitamin D/Calcium
1999
Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial)
2007
Alendronate Treatment of Established Primary Osteoporosis in Men: Results of a 2-Year Prospective Study
2001
Oral bisphosphonates reduce the risk of clinical fractures in glucocorticoid-induced osteoporosis in clinical practice
2012
Immigrantenosteomalazie
2000
Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study
2008
Vitamin D Deficiency and Osteopathies
1998
Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis
2009
Knochenmineralgehalt bei chronischer H�modialyse
1978
Die einheimische Sprue, oft verkannte Ursache hochgradiger generalisierter Osteopathien*
2008
Ergebnisse einer Langzeittherapie der primären Osteoporose mit Natriumfluorid*
1978
Morbus Paget des Knochens
1977
Effect of Monitoring Bone Turnover Markers on Persistence with Risedronate Treatment of Postmenopausal Osteoporosis
2007
Transdermal fentanyl for the treatment of back pain caused by vertebral osteoporosis
2002
Management of osteoporosis in the elderly
2009
Increasing skeletal involution in the elderly?
1985
Correlation of clinical, densitometric, and histomorphometric data in osteoporosis
1975
Bone turnover markers and bone mineral density response with risedronate therapy: Relationship with fracture risk and patient adherence
2011